2 Healthcare Stocks Under $5 Rated ‘Buy’ in the POWR Ratings -Breaking
[ad_1]
With the continued spread of the COVID-19 Delta variant in several parts of the world, the healthcare industry continues to command investors’ attention. Due to the growing demand for treatment for chronic diseases, this industry will continue growing. It is therefore a smart move to place your bets on healthcare stocks Global Cord Blood, (NASDAQ:) or So-Young International (NASDAQ.), both of which trade for less than $5 per shares. These names are also rated ‘Strong Buy’ or ‘Buy’ in our proprietary POWR Ratings system. Keep reading. To prevent and combat COVID-19 like situations, governments around the globe have made significant investments in their healthcare systems. As a result, demand is rising for solutions to chronic illnesses. These tailwinds are of import to Investors, whose interest in the healthcare stocks is evidenced by the Health Care Select Sector SPDR Fund’s (XLV) 16.2% year-to-date returns.
As China warns of the further spread of coronavirus, the healthcare industry will likely continue enjoying the market’s attention. According to Business Wire, the healthcare industry is projected to grow to $11.91 trillion in 2022, as per a report by Business Wire.
We believe it would be prudent to place a bet on global healthcare stocks Global Cord Blood Corporation and So-Young International Inc., which trade at $5 or less but have solid fundamentals. Furthermore, these stocks are rated ‘Strong Buy’ or ‘Buy’ in our proprietary POWR Ratings system.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]